Evista (Raloxifene HCI) more low Risk BREAST CANCER Invasive
Четверг, Январь 7th, 2010That - Evista (raloxifene)?:
Evista (raloxifene hydrochloride), - selective estrogen modulator of the receptor (SERM). This - not hormone. (далее…)
That - Evista (raloxifene)?:
Evista (raloxifene hydrochloride), - selective estrogen modulator of the receptor (SERM). This - not hormone. (далее…)
Raloxifene And composition of the body and power of the muscle in postmenopausal woman: mixed, double-blind, operated by test placebo (далее…)
The Study Tamoxifen and Raloxifene, or STARS, - проектое clinical test sees as medicine raloxifene is compared with medicine tamoxifen in reduction of incidence breast cancer in postmenopausal woman, who - in raised risk disease. (далее…)

Raloxifene - pharmacological action. The selective modulator estrogene receptors. Operates as agonist on the fabrics of the organism which has been not connected with a reproduction, and as the antagonist - on reproductive fabrics. (далее…)